Atul Pande Net Worth & Insider Trades

Atul Pande - Director, Sio Gene Therapies Inc

As of April 19, 2021

What is Atul Pande's Net Worth?

The current estimated net worth of Sio Gene Therapies Inc's Director, Atul Pande, is estimated to be about $7.62M . Atul Pande owns about 33,370 units of Sio Gene Therapies Inc common stock. In the last year at Sio Gene Therapies Inc, Atul Pande has sold an estimated value of $0 worth.

What is Atul Pande's Past Insider Trading?

Atul Pande's largest purchase order was 10,000 units , worth over $23.4K on November 25, 2020. In total, Atul Pande has made about 2 transactions over a year of their time at Sio Gene Therapies Inc. Atul Pande usually trades in November and April, with the busiest year in 2020 and 2021.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Atul Pande's' Mailing Address?

  • Mailing address is C/o Axovant Sciences, Inc. 1441 Broadway, 3rd Floor New York NY 10018 NY

Sio Gene Therapies Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Total
Pavan Cheruvu, M.D. 2020 $517,500 $388,815 $483,113 $19,191 $19,191 $1,706,699
Pavan Cheruvu, M.D. 2019 $500,000 $351,056 $1,784,077 $8,616 $8,616 $2,868,749
David Nassif, J.D. 2020 $414,000 $181,470 $225,415 $43,485 $43,485 $1,078,098
David Nassif, J.D. 2019 $300,000 $234,032 $970,828 $81,350 $81,350 $1,761,210
Gavin Corcoran, M.D. 2020 $433,500 $146,280 $181,989 $17,410 $17,410 $983,948
Gavin Corcoran, M.D. 2019 $425,000 $248,663 $628,885 $8,616 $8,616 $1,457,258
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1636050/000163605021000064/sioxdef14aaugust2021.htm

What are Sio Gene Therapies Inc's Past Insider Trades?

Sio Gene Therapies Inc's most recent insider trade came on March 24, 2021 by Pavan Cheruvu who bought 100,000 units worth $248.18K . In the last year, insiders at Sio Gene Therapies Inc have sold an estimated value of $30.07K and bought an estimated value of $271.58K worth of shares. Insider trading is most common in April, with the busiest year in 2021. The most active traders at the company are David Nassif, Interim CEO,  Pavan Cheruvu, Chief Executive Officer,  and Atul Pande, Director .

Sio Gene Therapies Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1